Clinical Trial Update: Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating paclitaxel in patients with metastatic or advanced gastrointestinal stromal tumors after failure of imatinib and sunitinib has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumors

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Asan Medical Center | Conditions: Gastrointestinal Stromal Tumors | Phase 2 | Status: COMPLETED